You searched for "visual"
RANZCO Congress 2025
The Royal Australian and New Zealand College of Ophthalmologists Annual Congress 2025XXII SARCS (State of the Art Refractive Cataract Surgery) Symposium 2024
by Andrew Bourne, BSc, MCOptom, DipTp(IP), Dip Glauc, Principal Optometrist, Hull & East Yorkshire Eye Hospital, UK. Once again, Milind Pande welcomed over 220 ophthalmologists and allied professionals to his annual symposium, this year held once again at the University...UK Eye Genetics Group (UK-EGG) 2024
by Mohammed Aslam, FY 3 Doctor, Calderdale and Huddersfield NHS Foundation Trust, UK. Founded in 2002, the UK EGG provides a hub to share knowledge on inherited eye disease and train the next generation of clinicians and scientists. This year’s...Moorfields: Vitreoretinal emergencies: A practical guide for health care professionals
Vitreoretinal emergencies: A practical guide for health care professionalsMoorfields: Ocular emergencies level 1
Designed for optometrists, orthoptists, nurses and other allied ophthalmic health professionals, this module will deliver the knowledge and skills required for the examination, investigation, diagnosis, treatment, and management of patients who present in an ophthalmic emergency setting. Entry requirementsBSc (Hons)...
Two-year GATHER2 data: anatomical gains, functional questions for avacincaptad pegol in geographic atrophy
Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) remains a leading cause of irreversible central vision loss, and complement dysregulation has long been implicated in its pathogenesis. In 2023, the US FDA approved the first two GA therapies, both...
Combined phacoemulsification and hydrus microstent for normal tension glaucoma
This retrospective multicentre study followed up 77 normal tension glaucoma (NTG) eyes undergoing phacoemulsification and Hydrus implantation between 2014 and 2023 over a 36-month period. Primary outcomes were changes in intraocular pressure (IOP) and medication burden, and cumulative success probabilities...New Moorfields stem cell treatment improves vision for untreatable condition
A new breakthrough stem cell treatment for ARK (aniridia-related keratopathy) has seen patients’ vision improve for this previously untreatable rare genetic eye condition in a first-in-human clinical trial at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, published in...Imaging without a slit-lamp, more Google Glass news and strabismus humour
Pinterest Many of you will know about this site that organises collections of mostly graphical information. It’s used heavily for fashion, recipes and cupcakes. Well, it seems it has also become quite a useful resource for ophthalmology, optometry and related...Seeing the Funny Side: Taking on the Edinburgh Fringe with Sight Loss
Comedian Jake Donaldson is partially blind, or partially sighted, depending on your outlook on life, but what’s it really like to be a visually impaired comedian?
AC/A non-linearity
This study investigated whether or not the response accommodative convergence to accommodation (AC/A) ratio in 30 visually normal subjects is linear with lens presentation order counterbalanced. Accommodative response was measured using the Shin Nippon SRW 500 infrared autorefractor. Accommodation was...
